Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monali Vasekar

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
BMJ Case Reports|November 8, 2023
Thoracic splenosis: an important consideration in oncology patientsKatherine Julian, Monali Vasekar
Current Allergy and Asthma Reports|December 1, 2011
ACE inhibitor-induced angioedemaMonali Vasekar, Timothy J Craig
Current Molecular Pharmacology|July 17, 2015
Immunotherapy in Bladder CancerMonali Vasekar, David Degraff, Monika Joshi
Advances in Experimental Medicine and Biology|January 5, 2013
Emerging molecular therapies for the treatment of acute lymphoblastic leukemiaMonali Vasekar, Joshua E Allen, Jamal Joudeh, et al.
World Journal of Clinical Oncology|May 16, 2014
Targeted immunotherapy for non-small cell lung cancerMonali Vasekar, Xin Liu, Hong Zheng, et al.
Case Reports in Oncological Medicine|April 8, 2020
Metastasis of Ewing Sarcoma to the Pancreas: Case Report and Literature ReviewHyma Polimera, Prashanth Moku, Shady Piedra Abusharar, et al.
Current Molecular Pharmacology|July 17, 2015
Novel Immunotherapies for Hematological MalignanciesMonali Vasekar, Syed Rizvi, Xin Liu, et al.
Journal of Geriatric Oncology|November 29, 2022
Alzheimer's disease and related dementias is a risk factor for lower utilization of breast cancer screening and unstaged cancer diagnosis: Observational study from SEER-Medicare 2004-2016 dataXingran Weng, Chan Shen, Monali Vasekar, et al.
Therapeutic Advances in Gastroenterology|March 2, 2016
Recent advances in pancreatic cancer: updates and insights from the 2015 annual meeting of the American Society of Clinical OncologyMatthew J Abrams, Kevin Rakszawski, Monali Vasekar, et al.
Annals of Surgical Oncology|October 31, 2020
Benefits of Surgical Treatment of Stage IV Breast Cancer for Patients With Known Hormone Receptor and HER2 StatusKelly Stahl, William Wong, Daleela Dodge, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|November 8, 2023
Thoracic splenosis: an important consideration in oncology patientsKatherine Julian, Monali Vasekar
Current Allergy and Asthma Reports|December 1, 2011
ACE inhibitor-induced angioedemaMonali Vasekar, Timothy J Craig
Current Molecular Pharmacology|July 17, 2015
Immunotherapy in Bladder CancerMonali Vasekar, David Degraff, Monika Joshi
Advances in Experimental Medicine and Biology|January 5, 2013
Emerging molecular therapies for the treatment of acute lymphoblastic leukemiaMonali Vasekar, Joshua E Allen, Jamal Joudeh, et al.
World Journal of Clinical Oncology|May 16, 2014
Targeted immunotherapy for non-small cell lung cancerMonali Vasekar, Xin Liu, Hong Zheng, et al.
Case Reports in Oncological Medicine|April 8, 2020
Metastasis of Ewing Sarcoma to the Pancreas: Case Report and Literature ReviewHyma Polimera, Prashanth Moku, Shady Piedra Abusharar, et al.
Current Molecular Pharmacology|July 17, 2015
Novel Immunotherapies for Hematological MalignanciesMonali Vasekar, Syed Rizvi, Xin Liu, et al.
Journal of Geriatric Oncology|November 29, 2022
Alzheimer's disease and related dementias is a risk factor for lower utilization of breast cancer screening and unstaged cancer diagnosis: Observational study from SEER-Medicare 2004-2016 dataXingran Weng, Chan Shen, Monali Vasekar, et al.
Therapeutic Advances in Gastroenterology|March 2, 2016
Recent advances in pancreatic cancer: updates and insights from the 2015 annual meeting of the American Society of Clinical OncologyMatthew J Abrams, Kevin Rakszawski, Monali Vasekar, et al.
Annals of Surgical Oncology|October 31, 2020
Benefits of Surgical Treatment of Stage IV Breast Cancer for Patients With Known Hormone Receptor and HER2 StatusKelly Stahl, William Wong, Daleela Dodge, et al.
Pageof 2